Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1040P is a human pseudogene derived from the U6 small nuclear RNA gene family, sharing significant sequence homology with functional U6 snRNAs but not producing a functional RNA molecule. U6 snRNA is essential for the catalytic steps of intron removal during pre-mRNA splicing and operates as a non-coding RNA at the heart of the spliceosome, but RNU6-1040P lacks functional activity and is likely the result of evolutionary duplication events[3][2][1]. The presence of multiple U6 pseudogenes in the genome reflects the evolutionary importance of this RNA, but these copies are generally inert and have no established biological or therapeutic function[2][3][1]. In sequencing studies, such pseudogenes may be identified by sequence homology but should not be confused with actively transcribed, functional targets. If searching for a drug target or functional receptor, "RNU6-1040P" is not an appropriate candidate due to its classification as a pseudogene.
None; not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 1040 pseudogene (RNU6-1040P).